• Latest Posts

The most effective Test for Ovarian Cancer raised €7.4M

Ipsen acquired OctreoPharm to strengthen its Oncology presence

PsiOxus raised €34.7 Million from First-Class investors

Baxter’s spinoff Baxalta is building up its Oncology portfolio

European companies present their cancer treatment solutions in the USA

Eli Lilly signs a €250M deal with BioNTech for new Cancer Immunotherapies

ADVERTISEMENT

PhoreMost awarded €1.96M to target the “undruggable” Cancer Genes

Natural Killer therapies for Cancer: a Fast-Evolving field

A new Microfluidic Chip technology raised €1.9Million

PEP-Therapy Raised €1.3 Million in Seed Capital

Are personalized treatments for lung cancer underutilized?

OncoBEAM blood test arrives to Europe

ADVERTISEMENT